Open-label Adjunctive Zonisamide for Bipolar Disorder

Trial Profile

Open-label Adjunctive Zonisamide for Bipolar Disorder

Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Elan Pharmaceuticals
  • Most Recent Events

    • 15 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top